These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 33737877)

  • 21. Review of thiamine deficiency disorders: Wernicke encephalopathy and Korsakoff psychosis.
    Chandrakumar A; Bhardwaj A; 't Jong GW
    J Basic Clin Physiol Pharmacol; 2018 Oct; 30(2):153-162. PubMed ID: 30281514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wernicke-Korsakoff-syndrome: under-recognized and under-treated.
    Isenberg-Grzeda E; Kutner HE; Nicolson SE
    Psychosomatics; 2012; 53(6):507-16. PubMed ID: 23157990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection.
    Copaescu A; Smibert O; Gibson A; Phillips EJ; Trubiano JA
    J Allergy Clin Immunol; 2020 Sep; 146(3):518-534.e1. PubMed ID: 32896310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent updates in the clinical trials of therapeutic monoclonal antibodies targeting cytokine storm for the management of COVID-19.
    Patel S; Saxena B; Mehta P
    Heliyon; 2021 Feb; 7(2):e06158. PubMed ID: 33553708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenylmethimazole is a candidate drug for the treatment of severe forms of coronavirus disease 2019 (COVID-19) as well as other virus-induced "cytokines storm".
    Giuliani C; Bucci I; Napolitano G
    Med Hypotheses; 2021 Jan; 146():110473. PubMed ID: 33385879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wernicke-Korsakoff syndrome and other diseases associated with thyamine deficiency.
    Mateos-Díaz AM; Marcos M; Chamorro AJ
    Med Clin (Barc); 2022 May; 158(9):431-436. PubMed ID: 35039171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
    Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
    Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of "Cytokine Storm" in Hospitalized COVID-19 Patients: A Retrospective Cohort Study.
    Ciampa ML; O'Hara TA; Joel CL; Gleaton MM; Tiwari KK; Boudreaux DM; Prasad BM
    Infect Dis Rep; 2021 Apr; 13(2):377-387. PubMed ID: 33921604
    [No Abstract]   [Full Text] [Related]  

  • 31. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
    Soy M; Keser G; Atagündüz P; Tabak F; Atagündüz I; Kayhan S
    Clin Rheumatol; 2020 Jul; 39(7):2085-2094. PubMed ID: 32474885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wernicke encephalopathy: limitations in a laboratory and radiological diagnosis.
    Ono K; Hayano S; Kashima M
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38081738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
    Shibabaw T
    J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
    Shawki MA; Elsayed NS; Mantawy EM; Said RS
    Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 Perpetrator of the COVID-19 Cytokine Storm.
    Shekhawat J; Gauba K; Gupta S; Purohit P; Mitra P; Garg M; Misra S; Sharma P; Banerjee M
    Indian J Clin Biochem; 2021 Oct; 36(4):440-450. PubMed ID: 34177139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
    Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA
    J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.
    Zanza C; Romenskaya T; Manetti AC; Franceschi F; La Russa R; Bertozzi G; Maiese A; Savioli G; Volonnino G; Longhitano Y
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208467
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.